Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06417216Not ApplicableSuspended

Head-Cancelled Virtual Reality for Ocular Cranial Nerve Palsies

Role: collaborator

NCT04066075Not ApplicableCompleted

Beacon Sensors and Telerehabilitation for Low Vision

Role: collaborator

NCT05829135Not ApplicableWithdrawn

Improving Glare and Visual Comfort for Patients With Visual Impairment

Role: collaborator

NCT04487249Not ApplicableRecruiting

Trial of Vision Therapy for Intermittent Exotropia

Role: collaborator

NCT00472212Not ApplicableCompleted

Correction of Farsightedness in Children Study

Role: collaborator

NCT03652337Not ApplicableActive Not Recruiting

Meibomian Gland Dysfunction Management

Role: collaborator

All 6 trials loaded